A protein antigen with an apparent molecular weight (Mr) of 31,000 was isolated from 0.2 M glycine hydrochloride (pH 2.2) extracts of a typical human fecal isolate, Campylobacterjejuni VC74. The protein was purified to homogeneity on a preparative scale by immunoaffinity chromatography followed by molecular sieving with a Superose 12 column. Isoelectric focusing under nondenaturing conditions indicated a pI of 9.3, and amino acid composition analysis showed that the protein was unusually rich in lysine, containing 14.9 mol% of this basic amino acid. Cysteine and tryptophan were absent. The protein also contained approximately 35% hydrophobic amino acid residues, and N-terminal amino acid analysis showed that 17 of the first 38 residues were hydrophobic. This amino-terminal sequence to residue 22 was virtually identical to that of an antigenically cross-reactive 31,000-Mr protein isolated from another C. jejuni strain belonging to a different heat-labile serogroup. Western blotting (immunoblotting) of glycine extracts of other C. jejuni, Campylobacter coli, and Campylobacter laridis strains belonging to different thermolabile and thermostable serotypes, as well as Campylobacterfetus, with a rabbit polyclonal antiserum raised against the purified C. jejuni VC74 protein showed that all C. jejuni, C. coli, and C. laridis strains tested contained a 31,000-Mr protein with epitopes which were antigenically cross-reactive with the C. jejuni VC74 protein. The antigenically cross-reactive epitopes of this protein were also readily detected by immunodot blot assay of glycine extracts of C. jejuni, C. coli, and C. taridis with monospecific polyclonal antisera to the 31,000-Mr protein, suggesting that this serological test could be a useful addition to those currently employed in the rapid identification of these important pathogens. Slide agglutination reactions, immunofluorescence assay, and immunogold electron microscopy with antisera to purified 31,000-Mr protein and trypsin treatment of whole cells indicated that the cross-reactive epitopes of the 31,000-Mr protein were not exposed on the cell surface. Cell fractionation analysis and immunogold electron microscopy located the protein on the outer surface of the cytoplasmic membrane. This finding suggests that the 31,000-Mr protein is not a good candidate for inclusion in a monovalent subunit Campylobacter vaccine.
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The thermophilic campylobacters, especially Campylobacterjejuni and Campylobacter coli, are now recognized as important gastrointestinal pathogens of humans, contributing substantially to morbidity in developed countries and to high mortality in developing countries (7, 44) . Because of the high incidence of Campylobacter disease worldwide, there is a need for effective vaccines to protect against infection by this group of organisms. The frequency of isolation of thermophilic campylobacters also means that they are the subject of many laboratory identification investigations and subsequent biotyping and serotyping studies. Unfortunately, despite numerous studies, campylobacters remain relatively difficult to rapidly identify, classify, and type biochemically. Members of the genus Campylobacter neither ferment nor oxidize carbohydrates and are inert in many other typical biochemical test media (15, 22, 36) , so there are only a few criteria which can be simply applied in their rapid identification (14, 15, 22, 26, 42) . A simple monovalent serological assay which could rapidly identify thermophilic campylobacters would clearly be useful. However, attempts to develop such a test have been unsuccessful because of the considerable serological diversity of the thermophilic campylobacters. This antigenic heterogeneity has also hampered vaccine development. For example, the heat-stable scheme of Penner and Hennessy (37) now contains >76 serotypes (Penner, personal communication) , while the heat-labile scheme of * Corresponding author.
Lior (27) contains >100 serotypes (Lior, personal communication) .
Western blot (immunoblot) studies of thermophilic Campylobacter species have identified a small number of proteins with antigenically cross-reactive epitopes (3, 4, 29, 32) . The immunodominant protein antigen of the thermophilic campylobacters is flagellin with a subunit molecular weight (Mr) of 59,000 to 61,000. However, while this protein carries cross-reactive epitopes, antibody absorption experiments employing live motile cells indicate that serospecific epitopes are predominant on the surface of the native flagella filament (30) . Furthermore, there are numerous serotypes of Campylobacter flagella (13, 16, 27, 45, 46) and these flagella are also subject to both phase and antigenic variation (6, 13) . This means that the Campylobacter flagella protein is neither a straightforward candidate for use in a monovalent vaccine nor as a target for an antibody-based identification test for thermophilic campylobacters. A second protein with crossreactive epitopes is the major outer membrane (OM) protein (3, 4, 29, 32) , but again, the majority of cross-reactive epitopes in this molecule likely represent conserved amino acid sequences buried in the OM (8, 19) . The third protein with cross-reactive epitopes is a protein with an apparent molecular weight of 31,000, which has been identified in glycine hydrochloride (pH 2.2) extracts of cells of thermophilic campylobacters (3, 4, 29, 32) . Indeed, the ability to remove the 31,000-Mr protein from cells by this simple extraction procedure has led to the widely held notion that the antigenically cross-reactive 31,000-Mr protein is located on the surface of the Campylobacter cell and is a prime candidate for inclusion in a monovalent subunit Campylobacter vaccine.
Because of the potential importance of such a crossreactive antigen in the prophylaxis and serological identification of thermophilic enteropathogenic Campylobacter species, we have isolated and purified a subunit 31,000-Mr acid-extractable cross-reactive protein antigen from a human fecal isolate of C. jejuni. In this study, we report on the biochemical characteristics of the protein and provide evidence that the protein may be unique to campylobacters. Further, we show that the protein is a good immunogen and that antibodies to the protein can be used to serologically identify thermophilic Campylobacter species. We also provide evidence that the protein is not located on the cell surface but is associated with the outer surface of the cytoplasmic membrane and so appears to be a poor candidate for inclusion in a Campylobacter vaccine.
MATERIALS AND METHODS Bacterial strains and growth conditions. All strains were from the culture collection in this laboratory, unless otherwise noted. C. jejuni strains were VC74 (LIO serogroup 11 (10) . The periplasmic fraction was prepared by the osmotic shock procedure of Willis et al. (47) ; cell envelopes and released OM vesicles were prepared by differential centrifugation as previously described (29) . The OM fraction was isolated from cell envelopes by the sodium lauryl sarcosinate procedure of Filip et al. (12) . Cells cultured for 24 and 48 h were also treated with trypsin (100 ,ug/ml for 1 h) and trypsin inhibitor as previously described (29 42 , the rabbits were exsanguinated and the serum was collected and stored at -20°C. Control nonimmune serum was obtained before the first injection.
To prepare an immunoaffinity gel to the 31,000-Mr protein, immunoglobulin G class antibodies in antiserum DD1 were separated by chromatography on a DEAE Affi-Gel Blue immunoglobulin G purification gel (Bio-Rad Laboratories) following the instructions of the manufacturer and coupled on CNBr-activated Sepharose 4B (Pharmacia, Uppsala, Sweden) following the instructions of the manufacturer. Remaining active groups were blocked with 0.1 M Tris hydrochloride (pH 8.0).
Protein purification. Two methods were used to purify the 31,000-Mr protein to homogeneity. By the first method, glycine extract was subjected to 70 to 80% ammonium sulfate precipitation and the pellet obtained by centrifugation at 16,000 x g for 30 min at 4°C was suspended in HPLCgrade distilled water and dialyzed overnight against this solvent. This material was subjected to HPLC. A Beckman HPLC system with a Brownlee RP8-Spheri 10 analytical column (4.6 by 250 mm) was used to separate the 31,000-Mr protein from minor contaminants. A 20 to 50% acetonitrile gradient in 0.1% trifluoroacetic acid was applied over 60 min. The flow rate was 1 ml/min, and chromatography was performed at room temperature. Fractions were concentrated and monitored by SDS-PAGE. The fraction containing a single band of an Mr of 31,000 was electroblotted to nitrocellulose paper and used to prepare polyclonal monospecific antiserum LAH31, as described above.
For preparative scale isolations, lyophilized glycine extract was rehydrated in 50 mM Tris hydrochloride (pH 8.0) and ultracentrifuged at 100,000 x g for 30 min at 4°C and the PROTEIN ANTIGEN SHARED BY THERMOPHILIC CAMPYLOBACTERS supernatant was dialyzed for 16 h against 50 mM Tris hydrochloride (pH 8.0). The sample was then applied to the Sepharose 4B immunoaffinity column. After sample application, the column was washed with 10 volumes of 50 mM Tris hydrochloride (pH 8.0) and then developed with 0.1 M glycine hydrochloride (pH 2.5) containing 0.5 M NaCI and 10% dioxane (Mallinckrodt, Inc., Paris, Ky.). The peak eluted from the column was concentrated by evaporation and dialyzed for 16 h against 20 mM Tris hydrochloride (pH 7.4) containing 0.1 M NaCl. Purification to homogeneity was achieved by molecular sieving on an FPLC system with a Superose 12 column (Pharmacia). The system was run in 20 mM Tris hydrochloride (pH 7.4) containing 0.1 M NaCl (Tris-NaCl) at a flow rate of 0.5 ml/min. The peaks eluted were monitored at 230 nm. After chromatography, the peaks of interest were collected, pooled, and concentrated by evaporation. After addition of 0.2% (wt/vol) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) (Sigma Chemical Co., St. Louis, Mo.), the sample was rechromatographed in 20 mM Tris-NaCl buffer containing 0.2% (wt/vol) CHAPS.
Amino acid composition analysis. The purified protein was dialyzed extensively against distilled water, lyophilized, and then hydrolyzed in 6 N HCl at 100°C for 18 h. Amino acid composition was determined on a 119CL Beckman amino acid analyzer. The method used was as described by the manufacturer for a 90-min single column procedure. Cysteine was analyzed as cysteic acid after performic acid oxidation (17) . Tryptophan was determined by the method of Penke et al. (35) , which involved hydrolysis of the protein with mercaptoethanesulfonic acid.
N-terminal sequence analysis. Amino acid sequence analysis was performed on an Applied Biosystems model 470A gas phase sequenator (Applied Biosystems, Foster City, Calif.) running a standard operating program. Phenylthiohydantoin derivatives were separated on an IBM cyanocolumn (4.6 by 250 mm) as described by Hunkapiller and Hood (20) fitted to a Beckman model 332 high-pressure liquid chromatograph equipped with a Hewlett-Packard 3390A integrator (Hewlett-Packard Co., Palo Alto, Calif.). The aminoterminal sequence of the 31,000-Mr protein of C. jejuni VC96 was determined after electrophoretic separation of a glycine extract on a 12.5% acrylamide gel and electroblotting to an Immobilon transfer membrane (Millipore Corp., Bedford, Mass.) by the method of LeGendre and Matsudaira (25 Indirect fluorescent-antibody testing. Indirect fluorescentantibody testing was performed as previously described (30) . RESULTS 
AND DISCUSSION
The most efficient recovery of the 31,000Mr protein was obtained by the glycine buffer (pH 2.2) extraction procedure of McCoy et al. (31) with cells cultured for 48 h. This technique was used by McCoy and co-workers to preferentially isolate the surface layer protein from C. fetus. The method has also been successfully employed to isolate surface layer proteins from Aeromonas species (9) and flagella from Campylobacter species (29, 30) . SDS-PAGE analysis showed that the 31,000-Mr protein and the 61,000-Mr flagellin protein (3, 4, 29, 30, 33) were the principal components in the glycine extract. The 45,000-Mr major outer membrane protein was also present (3, 4, 29, 32), indicating contamination by OM material, presumably as vesicles.
To purify sufficient protein to allow antibodies to be prepared for subsequent immunoaffinity purification, the 31,000-Mr protein was cut directly from an SDS-PAGE gel of the glycine-extracted fraction and used to immunize a rabbit (antiserum DD1). In an alternative procedure, a 70 to 80% ammonium sulfate fraction was subjected to HPLC by using a reverse-phase C8 Spheri-10 column and a 20 to 50% gradient of acetonitrile in a 0.1% trifluoroacetic acid-acetonitrile system. The 31,000-Mr protein was eluted at approximately 39% acetonitrile. This fraction contained a single band, which was electroblotted to NCP, and this was used to prepare polyclonal monospecific antiserum LAH31.
For preparative scale isolation of the 31,000-Mr protein, immunoaffinity chromatography was employed. Contaminating flagella and OM material were removed from a rehydrated glycine extract by ultracentrifugation, and the supernatant was chromatographed on the Sepharose 4B anti-31,000-Mr immunoaffinity column (antiserum DD1). The 31,000-Mr protein bound rather tightly to the antibodies on the immunoaffinity column, and desorption required an elution buffer that combined a low pH, high salt concentration, and 10% dioxane to lower the polarity of the eluent. The peak obtained was highly enriched for the 31,000-Mr protein.
Purification to homogeneity required two additional steps, both involving molecular sieving with a Superose 12 column coupled to an FPLC system but with two different solvent systems. The peak eluted from the immunoaffinity column was first chromatographed in 20 mM Tris hydrochloride buffer (pH 7.4) containing 0.1 M NaCl. The peak eluting around 23 min was pooled and concentrated. The mild dipolar ionic detergent CHAPS with its bile salt hydrophobic group and a sulfobetaine hydrophilic head group was then added at 0.2% (wt/vol) to both the sample and the elution buffer to overcome aggregation problems (18) . Separation in this solvent gave a major peak which contained only a single band with an apparent Mr of 31,000 on SDS-PAGE (Fig. 1) . Amino acid composition analysis of the 31,000-Mr protein purified from C. jejuni VC74 showed that the protein contained approximately 279 residues per molecule (Table 1) , with a predicted Mr of 30,960, very similar to the 31,000 estimated by SDS-PAGE. Glx, Asx, Ala, Leu, Lys, and Gly were prominent, but cysteine and tryptophan were absent. The calculated relative hydrophobicity (assuming Val, Met, Ile, Leu, Ala, Phe, Try, and Pro) was approximately 35.5%. When isoelectric focusing was performed in a mini-gel system under nondenaturing conditions, the protein focused into a single band at a pI equal to 9.3, showing that in its nondenatured conformation the 31,000-Mr protein was a basic protein. Indeed, the VC74 protein was especially rich in lysine approximatelyy 14.3% of the residues). This percentage is twice that generally found in proteins (23) , although a protein with a similar pI has recently been reported for Yersinia pseudotuberculosis (40) . However, this antiphagocytic plasmid-encoded Yop2b protein contains a high content of histidine (5), in contrast to the high lysine content of the Campylobacter protein.
The N-terminal amino acid sequence of the VC74 protein was determined for the first 38 residues (Table 2 ). This sequence contained 45% hydrophobic amino acids, including a methionine at residue 23, as well as 11% basic and 13% acidic amino acids. The antigenically cross-reactive 31,000- Mr protein of C. jejuni VC96 was also selectively isolated from glycine extracts by the Immobilon transfer technique (25) and, when subjected to N-terminal amino acid sequence analysis, exhibited a sequence virtually identical to the VC74 protein to residue 22. The single difference of an Ala for an Asp at residue 13 could result from a single nucleotide change at the codon level. A search of the National Biomedical Research Foundation protein sequence library failed to reveal any sequences with significant homology to the Nterminal of the 31,000-Mr protein (28) , which suggests that it may be a protein unique to Campylobacter species. The 31,000-Mr protein was a good immunogen in rabbits, both when rabbits were immunized with the purified C. jejuni VC74 31,000-Mr protein or with intact formalinized C. jejuni VC74 cells. Western blotting of glycine extracts of a range of Campylobacter species with antisera DD2 or LAH31 to the VC74 31,000-Mr protein showed that an antigenically cross-reactive protein with an Mr of 31,000 was present in all C. jejuni and C. coli strains tested, regardless of heat-labile serotype. The protein was also present in C. laridis, which can also cause enteritis in humans (36), but was not present in glycine extracts of C. fetus. Identical results were also obtained with antiserum SML1 prepared against intact cells of VC74. Figure 2 shows the results obtained when antiserum DD2 was reacted with C. jejuni VC74, VC79, VC82, VC83, VC88, VC90, VC91, VC94, VC105, VC118, and VC206 (lanes 1 to 11); C. coii VC5O, VC51, VC80, VC84, VC93, VC96, VC97, and VC113 (lanes 12 to 19); C. laridis VC81 (lane 20); and C. fetus VC78 and VC119 (lanes 21 and 22) . The peptide was not present in glycine extracts of control strains A. hydrophila TF7 (lane 23) and E. coli HB101 (data not shown). A dot blot assay of glycine extracts with the monospecific polyclonal antisera further revealed that the cross-reactive epitopes could be readily used to detect C. jejuni, C. coli, and C. Iaridis. Weaker, but still positive, signals were also obtained with glycine extracts of "C. upsaliensis," and C. cinaedi. "C. upsaliensis" is a newly described catalase-negative or weakly positive species of the genus Campylobacter and has been isolated with gastroenteritis in humans and dogs (34, 41) , while C. cinaedi has been associated with proctitis and enteritis in homosexual males (11) . This latter Campylobacter species does not grow at 42°C, however, and should neither be coisolated nor have its identity confused with the much more common thermophilic enteropathogenic species of the genus Campylobacter. No reaction was seen with glycine extracts of C. fetus, the catalase-positive C. cryaero- phila, or the nonspiral enteric pathogens tested, including E. coli, Salmonella species, and S. flexneri (Fig. 3) . Initial reports of the 31,000-Mr antigenically cross-reactive protein of Campylobacter species had suggested that the antigen was positioned on the cell surface by virtue of its sensitivity to trypsin and by its ability to be iodinated by the lactoperoxidase surface radiolabeling technique (3, 29, 32) . These studies were performed on cells grown for 48 h. When we treated 24-h-old cells with trypsin, there was no loss of epitope reactivity although the protein was susceptible to trypsin cleavage in 48-h cultures and when purified (Fig. 4,  lanes 2 to 5) . Moreover, monospecific antisera DD2 and LAH31 both failed to agglutinate cells of homologous strain C. jejuni VC74 and indirect fluorescent-antibody testing and immunogold electronmicroscopy with these antisera failed to reveal antibody binding to the cell surface or to released OM (Fig. SA) . Cell fractionation studies further showed that the protein was not present in the released OM vesicle fraction (Fig. 4, lane 6) , and although the protein was present in the cell envelope fraction (Fig. 4, lane 7) , it did not copurify with OM prepared by sarcosyl solubilization (Fig.  4, lane 8) . Unfortunately, because of extensive fusions between the two membranes, physical separation procedures, such as sucrose gradients, do not allow separation of the outer and inner membranes of Campylobacter species (33); however, the protein was sarcosyl soluble (Fig. 4, (Fig. 5A) , but, as the Campylobacter culture aged, an increasing number of cells lysed and either released or exposed their cytoplasmic membrane and antibodies to the 31,000-Mr cross-reactive protein were seen to bind to the surface of this membrane (Fig. 5B and C) 46, 1989) , this seroconversion must result from antigen exposure during cell lysis or during macrophage processing. The fact that the epitopes are not exposed on the cell surface does not rule out their potential diagnostic value, however, and indeed may be fortuitous when it comes to development of a specific serological test for the thermophilic enteropathogenic campylobacters, given the serologic diversity of the surface of the Campylobacter cell. Crude glycine extracts are already used to detect anti-Campylobacter antibodies (38) . However, these crude extracts contain antigenically variable components such as flagellin and lipopolysaccharide, so use of the purified antigenically crossreactive 31,000-Mr protein should improve the specificity of detection of anti-Campylobacter antibodies in sera from patients. Antisera to the 31,000-Mr protein can also be used for rapid laboratory identification of such isolates as those from Campylobacter species. Glycine extraction to release the antigen is easy to perform and can be done on a small scale, such as in microcentrifuge tubes, and the immunodot blot assay is within the capabilities of most laboratories and is simple to perform on a routine basis. The nucleotide sequence encoding the thermophilic campylobacter-specific epitope could also provide for a DNA probe. Efforts are therefore underway to clone the gene coding for the 31,000-Mr cross-reactive protein antigen of the thermophilic enteropathogenic campylobacters.
